Cargando…

Effect of Health Information Technologies on Glycemic Control Among Patients with Type 2 Diabetes

PURPOSE OF REVIEW: This study was to present meta-analysis findings across selected clinical trials for the effect of health information technologies (HITs) on glycemic control among patients with type 2 diabetes. RECENT FINDINGS: HITs may be promising in diabetes management. However, findings on ef...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshida, Yilin, Boren, Suzanne A., Soares, Jesus, Popescu, Mihail, Nielson, Stephen D., Simoes, Eduardo J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2018
Materias:	Therapies and New Technologies in the Treatment of Diabetes (M Pietropaolo, Section Editor)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209028/ https://www.ncbi.nlm.nih.gov/pubmed/30338403 http://dx.doi.org/10.1007/s11892-018-1105-2

Ejemplares similares

Advanced Technology in the Management of Diabetes: Which Comes First—Continuous Glucose Monitor or Insulin Pump?
por: Martin, Christopher T., et al.
Publicado: (2019)

Effect of Health Information Technologies on Cardiovascular Risk Factors among Patients with Diabetes
por: Yoshida, Yilin, et al.
Publicado: (2019)

Management of Type 1 Diabetes in Pregnancy
por: Feldman, Anna Z., et al.
Publicado: (2016)

A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes
por: King, Allen B., et al.
Publicado: (2016)

DPP-4 Inhibitors: Impact on glycemic control and cardiovascular risk factors
por: Dicker, Dror
Publicado: (2011)

Glycemic Control Impact on Body Weight Potential to Reduce Cardiovascular Risk: Glucagon-like peptide 1 agonists
por: Sesti, Giorgio
Publicado: (2011)

In Vivo Actions of Peroxisome Proliferator–Activated Receptors: Glycemic control, insulin sensitivity, and insulin secretion
por: Eldor, Roy, et al.
Publicado: (2013)

Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Alogliptin in Patients With Type 2 Diabetes and Inadequate Glycemic Control: A randomized, double-blind, placebo-controlled study
por: DeFronzo, Ralph A., et al.
Publicado: (2008)

Target for Glycemic Control: Concentrating on glucose
por: Monnier, Louis, et al.
Publicado: (2009)

New intrauterine technologies for contraception and treatment in nulliparous/adolescent and parous women
por: Wildemeersch, D.
Publicado: (2009)

SERENADE: The Study Evaluating Rimonabant Efficacy in Drug-Naive Diabetic Patients : Effects of monotherapy with rimonabant, the first selective CB(1) receptor antagonist, on glycemic control, body weight, and lipid profile in drug-naive type 2 diabetes
por: Rosenstock, Julio, et al.
Publicado: (2008)

Accuracy and Glycemic Efficacy of Continuous Glucose Monitors in Critically Ill COVID-19 Patients: A Retrospective Study
por: Boeder, Schafer, et al.
Publicado: (2022)

Using outcomes data to justify instituting new technology: a single institution’s experience
por: Starker, P. M., et al.
Publicado: (2017)

Type 2 Diabetes Can Be Prevented With Early Pharmacological Intervention
por: DeFronzo, Ralph A., et al.
Publicado: (2011)

Long-Term Benefits From Lifestyle Interventions for Type 2 Diabetes Prevention: Time to expand the efforts
por: Tuomilehto, Jaakko, et al.
Publicado: (2011)

Safety of PPAR Agonists
por: Home, Philip
Publicado: (2011)

Pivotal Role of Timely Basal Insulin Replacement After Metformin Failure in Sustaining Long-Term Blood Glucose Control at a Target in Type 2 Diabetes
por: Bolli, Geremia B., et al.
Publicado: (2011)

Insulin: Potential Negative Consequences of Early Routine Use in Patients With Type 2 Diabetes
por: Lebovitz, Harold E.
Publicado: (2011)

Multidrug Treatment of Type 2 Diabetes: A challenge for compliance
por: Miccoli, Roberto, et al.
Publicado: (2011)

Glucokinase Activators for Diabetes Therapy: May 2010 status report
por: Matschinsky, Franz M., et al.
Publicado: (2011)

Role of Bile Acid Sequestrants in the Treatment of Type 2 Diabetes
por: Handelsman, Yehuda
Publicado: (2011)

Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes
por: Holst, Jens J., et al.
Publicado: (2011)

Incretin Effects on β-Cell Function, Replication, and Mass: The human perspective
por: Garber, Alan J.
Publicado: (2011)

Therapy in the Early Stage: Incretins
por: Cernea, Simona, et al.
Publicado: (2011)

Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A review of their efficacy and tolerability
por: Garber, Alan J.
Publicado: (2011)

An Outline of the Allen Method
Publicado: (1919)

Goals of Treatment for Type 2 Diabetes: β-Cell preservation for glycemic control
por: Marchetti, Piero, et al.
Publicado: (2009)

The effect of intracoronary infusion of bone marrow‐derived mononuclear cells on all‐cause mortality in acute myocardial infarction: rationale and design of the BAMI trial
por: Mathur, Anthony, et al.
Publicado: (2017)

A Phase 2a dose‐escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS‐986231 in hospitalized patients with heart failure with reduced ejection fraction
por: Tita, Cristina, et al.
Publicado: (2017)

Balloon-assisted Transcatheter arterial embolization using N-butyl cyanoacrylate for iatrogenic arterial bleeding by groin puncture: a new technology
por: Ueda, Tatsuo, et al.
Publicado: (2020)

Can surgical skills be taught using technological advances online? A comparative study of online and face-to-face surgical skills training
por: Fehervari, Matyas, et al.
Publicado: (2022)

The Promises and Pitfalls of Digital Technology in Its Application to Alcohol Treatment
por: Muench, Frederick
Publicado: (2014)

Embolization of medium-sized vessels with the penumbra occlusion device: evaluation of anchoring function
por: Kato, Kenichi, et al.
Publicado: (2020)

How Do We Continue Treatment in Patients With Type 2 Diabetes When Therapeutic Goals Are Not Reached With Oral Antidiabetes Agents and Lifestyle? Incretin versus insulin treatment
por: Gallwitz, Baptist, et al.
Publicado: (2013)

Is Physical Exercise a Core Therapeutical Element for Most Patients With Type 2 Diabetes?
por: De Feo, Pierpaolo, et al.
Publicado: (2013)

Activation of GPR40 as a Therapeutic Target for the Treatment of Type 2 Diabetes
por: Burant, Charles F.
Publicado: (2013)

Do We Still Need Pioglitazone for the Treatment of Type 2 Diabetes? A risk-benefit critique in 2013
por: Schernthaner, Guntram, et al.
Publicado: (2013)

Peptide crosslinked micelles: a new strategy for the design and synthesis of peptide vaccines
por: Hao, Jihua, et al.
Publicado: (2006)

On the way to building an integrated computational environment for the study of developmental patterns and genetic diseases
por: Turinsky, Andrei L, et al.
Publicado: (2006)

Spatial control over cell attachment by partial solvent entrapment of poly lysine in microfluidic channels
por: Baman, Nicki K, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_5gmoehn462lm9fbgfma00voe41